Oncolytics Biotech Files Form 8-K
Oncolytics Biotech filed a Form 8-K on November 4.
Related stories
Skue Sparebank Reports Q3 Pretax Profit of NOK 102.5 Million
M impact | EQUITY | Nov 04, 2026, 03:33 PM UTC
Microsoft Shares Hit Record High, Up 6.1%
M impact | EQUITY | Nov 04, 2026, 03:32 PM UTC
IMFA Q2 Profit Jumps 51% to Rs 149 Crore
Indian Metals & Ferro Alloys Ltd reported Q2 FY27 profit after tax of Rs 148.77 crore, compared with Rs 98.77 crore a year earlier. Revenue rose 35%.
M impact | EQUITY | Nov 04, 2026, 03:32 PM UTC
US Data Center Stocks Plunge After Democrats’ Midterm Wins
US data center stocks fell after Democrats won big in the midterm elections, amid concerns a sweep could constrain industry expansion.
M impact | EQUITY | Nov 04, 2026, 03:31 PM UTC
Madison Square Garden Entertainment Reports Fiscal Q1 Results
Madison Square Garden Entertainment reported results for the fiscal first quarter ended September 30, 2026. The available report describes a diverse slate of live entertainment off
M impact | EQUITY | Nov 04, 2026, 03:31 PM UTC
CHSN: trading halted on Nasdaq — volatility pause (10:30 AM ET)
Nasdaq halted trading in CHSN (volatility pause) at 10:30 AM ET.
M impact | EQUITY | Nov 04, 2026, 03:31 PM UTC